These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2044704)

  • 1. Leishmania donovani in hamsters: stimulation of non-specific resistance by some novel glycopeptides and impact on therapeutic efficacy.
    Pal R; Anuradha ; Rizvi SY; Kundu B; Mathur KB; Katiyar JC
    Experientia; 1991 May; 47(5):486-90. PubMed ID: 2044704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania donovani in hamsters: stimulation of non-specific resistance by novel lipopeptides and their effect in antileishmanial therapy.
    Zehra K; Pal R; Anuradha ; Rizvi SY; Haq W; Kundu B; Katiyar JC; Mathur KB
    Experientia; 1995 Jul; 51(7):725-30. PubMed ID: 7628580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of human beta-casein fragment (54-59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters.
    Sharma P; Singh N; Garg R; Haq W; Dube A
    Peptides; 2004 Nov; 25(11):1873-81. PubMed ID: 15501518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory activity of analog of muramyl dipeptide and their use as adjunct to chemotherapy of Leishmania donovani in hamster.
    Puri A; Sahai R; Haq W; Zaidi A; Guru PY; Tripathi LM; Srivastava VM
    Int Immunopharmacol; 2005 Jun; 5(6):937-46. PubMed ID: 15829410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ureastibamine on Leishmania donovani amastigote.
    Ghosh AK; Mukerji K; Ghosh DK
    Indian J Med Res; 1990 May; 91():208-13. PubMed ID: 2397943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural study on the antileishmanial effect of 1,2-dimethyl-3-methoxy carbonyl-4-(2-nitro-4,5-dimethoxyphenyl) pyrrole in hamsters.
    Bhatnagar S; Maitra SC; Guru PY; Katiyar JC
    Indian J Med Res; 1991 May; 93():147-51. PubMed ID: 1657768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
    Parant M; Riveau G; Parant F; Dinarello CA; Wolff SM; Chedid L
    J Infect Dis; 1980 Nov; 142(5):708-15. PubMed ID: 7462686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimmunomodulatory effects of morphine in Leishmania donovani-infected hamsters.
    Singal P; Kinhikar AG; Singh S; Singh PP
    Neuroimmunomodulation; 2002-2003; 10(5):261-9. PubMed ID: 12759563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intake of nutrient supplements affects multiplication of Leishmania donovani in hamsters.
    Garg R; Singh N; Dube A
    Parasitology; 2004 Dec; 129(Pt 6):685-91. PubMed ID: 15648691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
    J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis.
    Singh N; Mishra PK; Kapil A; Arya KR; Maurya R; Dube A
    J Ethnopharmacol; 2005 Apr; 98(1-2):83-8. PubMed ID: 15763367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effect of Arabinosylated lipoarabinomannan restrict the progression of visceral leishmaniasis through NOD2 inflammatory pathway: Functional regulation of T cell subsets.
    Jawed JJ; Banerjee S; Bandyopadhyay S; Parveen S; Chowdhury BP; Saini P; Majumdar S
    Biomed Pharmacother; 2018 Oct; 106():724-732. PubMed ID: 29990864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
    Gupta S; Yardley V; Vishwakarma P; Shivahare R; Sharma B; Launay D; Martin D; Puri SK
    J Antimicrob Chemother; 2015 Feb; 70(2):518-27. PubMed ID: 25389223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a diverse indole-2-carboxamides as a potent antileishmanial chemotypes.
    Pandey S; Chauhan SS; Shivahare R; Sharma A; Jaiswal S; Gupta S; Lal J; Chauhan PM
    Eur J Med Chem; 2016 Mar; 110():237-45. PubMed ID: 26840364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a bis(benzyl)polyamine analogue, and DL-alpha-difluoromethylornithine on parasite suppression and cellular polyamine levels in golden hamster during Leishmania donovani infection.
    Mukhopadhyay R; Madhubala R
    Pharmacol Res; 1993 Dec; 28(4):359-65. PubMed ID: 8140036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonspecific enhancement of resistance to local bacterial infection in starved mice.
    Galland RB; Trachtenberg LS; Rynerson N; Polk HC
    Arch Surg; 1982 Feb; 117(2):161-4. PubMed ID: 7034676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity and modification of hepatic xenobiotic metabolizing enzymes in golden hamster by 2(3)-tert-butyl-4-hydroxyanisole following infection with Leishmania donovani.
    Mukhopadhyay R; Madhubala R
    Biochem Pharmacol; 1994 Jan; 47(2):253-6. PubMed ID: 8304969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.